Unlock instant, AI-driven research and patent intelligence for your innovation.

Medium combination for suspension culture of human-derived cells and preparation method for oncolytic vaccinia virus

A technology of cell suspension and vaccinia virus, which is applied in the direction of cell culture active agents, biochemical equipment and methods, viruses, etc., can solve the problems of drop, drop of cell viability, low viability, etc., and achieve reduction of culture volume, simplification of operation, The effect of reducing labor intensity

Active Publication Date: 2020-10-02
TOT BIOPHARM CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The patent published by Transgene once reported that after HeLa S3 cells were acclimatized in suspension, the ability to amplify JX594 (Wyeth strain) virus decreased significantly, and the single-cell toxin production decreased from 72 pfu / cell (adhesive culture) to 0.4 pfu / cell ( Suspension culture), lost commercial application value
In addition, HeLa S3 cells are sensitive to shear force. When cultured in suspension, shake flask culture can grow well. Once enlarged to a reactor with stirring culture, the cells cannot grow normally, and the cell viability will drop sharply.
In summary, the effect of suspension culture of human cells has a significant impact on the production of oncolytic vaccinia virus
However, at present, the suspension culture of human cells still has the problems of insufficient density and low viability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medium combination for suspension culture of human-derived cells and preparation method for oncolytic vaccinia virus
  • Medium combination for suspension culture of human-derived cells and preparation method for oncolytic vaccinia virus
  • Medium combination for suspension culture of human-derived cells and preparation method for oncolytic vaccinia virus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Embodiment 1. Serum-free suspension culture of virus host cell HeLa S3

[0041] 1.1 HeLa S3 cell adherent subculture

[0042] (1) Cell source: cervical cancer cells, purchased from the American Type Culture Collection, HeLa S3 (ATCC®CCL2.2™), amplified after acquisition, subpackaged and frozen.

[0043] (2) Medium: DMEM (5% FBS), refers to DMEM medium containing 5% fetal bovine serum.

[0044] (3) Resuscitation: Resuscitate one HeLa S3 cell from liquid nitrogen, transfer it into a T25 square flask, and culture it in DMEM (5% FBS).

[0045] (4) After 2-4 days of culture, when the confluence of HeLa S3 cells grows in T25 square flasks to 80%~100%, rinse the cells with D-PBS solution, add trypsin to digest, resuspend with medium, gently Pipette the cells to disperse, passage to T75 square flask at 1:3~1:5 for further culture. After 2 to 4 days, the cells were subcultured into T175 square flasks to continue culturing in the same way.

[0046] 1.2 Suspension acclimation ...

Embodiment 2

[0050] Example 2 Culture medium combination

[0051] There are not many serum-free media available in the market for HeLa S3 cell culture, and most of them can only support the adherent growth of HeLaS3 cells, and very few support the suspension growth of HeLa S3 cells, even the cells that support the suspension growth of HeLa S3 cells Medium, cell growth is not good.

[0052] In this example, with EX-Cell ® 293, DMEM, VirusPro ® Two or three of CD HeLa were combined in equal proportions to form a new serum-free medium, and HeLa S3 cells were cultured in suspension in 125ml shake flasks, initial cell seeding density: 7.5×10 5 cells / ml, 37℃, 5%CO 2 , 110rpm shaking culture. After 3 days of culture, the cell seeding density was about 0.8×10 6 Cells / ml was subcultured, and after continuing to culture for 3 days, the cell density and viability were detected. The results are shown in Table 1:

[0053] Table 1 Cell density and viability after culture

[0054]

[0055] Th...

Embodiment 3

[0059] Embodiment 3 different culture medium combination expands virus

[0060] 3.1 Experimental method

[0061] Cell line: HeLa S3 (serum-free suspension culture)

[0062] Vaccinia virus: Lister strain, a genetically modified recombinant vaccinia virus strain

[0063] Medium:

[0064] ①EX-Cell ® 293+ DMEM (1:1)

[0065] ② Virus Pro ® CD HeLa + DMEM (1:1)

[0066] ③VirusPro ® CD HeLa + EX-Cell ® 293 (1:1)

[0067]④EX-Cell ® 293+ VirusPro ® CD HeLa+DMEM (1:1:1)

[0068] Cell culture: use the above four medium combinations to culture HeLa S3 cells respectively, 25ml / bottle, when the growth reaches the third day, take samples respectively to detect the cell density. Dilute to about 4×10 with the corresponding medium 6 cells / ml, ready to receive poison.

[0069] Virus amplification: Calculate the amount of virus seed incorporation according to the MOI of 0.02 pfu / cell, and inoculate Lister virus into the cells cultured in the four groups of medium. After conti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of preparation of oncolytic virus, in particular to a culture medium combination of a human source cell suspension culture and a preparation method of oncolytic vaccinia virus. The culture medium combination provided by the invention comprises at least two of an EX-Cell-293 culture medium, a VirusPro-CD HeLa culture medium and DMEM culture medium. The culture medium combination enables the suspended cultured HeLa S3 cells to maintain high-density high-activity growth and support large-scale culture of cell amplification viruses in a stirred bioreactor. Meanwhile, the HeLa S3 cells are suspended and cultured to amplify the vaccinia virus, the virus titer is also stabilized at a relatively high level, and the large-scale production of the oncolytic vaccinia virus is realized.

Description

technical field [0001] The invention relates to the technical field of oncolytic virus preparation, in particular to a medium combination for suspension culture of human cells and a preparation method of oncolytic vaccinia virus. Background technique [0002] Oncolytic Virus can target and kill tumor cells without killing normal tissue cells. At the same time, the oncolytic virus can kill those anti-apoptotic tumor cells, and will not produce antagonism to the existing anti-tumor treatment scheme, so it is suitable for combination therapy. [0003] Vaccinia Virus (VACV) was widely used in the global eradication of smallpox, and humans have a relatively in-depth understanding of the biological characteristics and pathogenic mechanism of vaccinia virus. At the same time, vaccinia virus replicates quickly, has clear side effects, has a large genome, and can insert large fragments of foreign genes, making it suitable for tumor treatment after modification. Vaccinia viruses use...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/09C12N7/00
CPCC12N5/0693C12N7/00C12N2501/105C12N2501/11C12N2501/113C12N2501/115C12N2501/119C12N2501/305C12N2501/33C12N2710/24051
Inventor 曾宇明范琦李坤刘冬连
Owner TOT BIOPHARM CO LTD